Aurobindo Pharma Q1 net slides 32% to ₹520 cr.
[ad_1] Drugmaker Aurobindo Pharma reported first-quarter consolidated net profit slid more than 32% to ₹520.3 crore. The net profit declined on an almost 9% increase in net sales to ₹6,176.8 crore (₹5,691.8 crore). Total income at ₹6,276.5 crore (₹5,811.8 crore) was almost 8% higher. The EBITDA margin stood at 15.5% as against 21.2% in the […]
Continue Reading